THIOPENTONE IS STILL KING OF THE IV INDUCTION AGENTS Newsletter Article 15 February 2013 Pages: 2 - 2
PATIENT PACKAGE INSERTS FOR BETTER PATIENT COMPLIANCE Newsletter Article 15 February 2013 Pages: 3 - 3
CLONIDINE OVERDOSE — SUGAR COATED PILLS INCREASE THE PROBLEM Newsletter Article 15 February 2013 Pages: 4 - 4
EFFECT OF THE NEWER ANTI-INFLAMMATORIES ON RENAL FUNCTION Newsletter Article 15 February 2013 Pages: 5 - 5
NON-STEROIDAL ANTI-INFLAMMATORIES — How Safe for Aspirin Sensitive Patients? Newsletter Article 15 February 2013 Pages: 5 - 5
IM INJECTION COMPLICATIONS — HOW IMPORTANT ARE THEY? Newsletter Article 15 February 2013 Pages: 5 - 6
LEVODOPA NOT RESPONSIBLE FOR THE INCREASE IN MALIGNANT MELANOMA Newsletter Article 15 February 2013 Pages: 6 - 6
BRL 10833 — Opens the way to further development in bronchodilators Newsletter Article 15 February 2013 Pages: 7 - 7
‘DEBRISAN’: A COMPLETELY NEW APPROACH TO INFECTED WOUNDS Newsletter Article 15 February 2013 Pages: 8 - 8
WHEN GRAM-POSITIVE MENINGITIS DOES NOT RESPOND TO PENICILLINS — Newsletter Article 15 February 2013 Pages: 9 - 9
LEVAMISOLE SHOWS PROMISE IN RECURRENT APHTHOUS STOMATITIS Newsletter Article 15 February 2013 Pages: 9 - 9
DIGITALISED PATIENTS GIVEN QUINIDINE SHOULD BE WATCHED CLOSELY Newsletter Article 15 February 2013 Pages: 13 - 13
WHEN EVALUATING NEW DRUGS — Variations in carbon oxidation should be considered Newsletter Article 15 February 2013 Pages: 14 - 14
PROCAINAMIDE KINETICS CHANGED AFTER ACUTE MYOCARDIAL INFARCTION Newsletter Article 15 February 2013 Pages: 15 - 15
METRONIDAZOLE KINETICS STUDIED IN RELATION TO CLINICAL COURSE Newsletter Article 15 February 2013 Pages: 16 - 16
VACCINES AGAINST CANCER — WHAT ARE THE POSSIBILITIES? Newsletter Article 15 February 2013 Pages: 17 - 17
PARKINSON’S DISEASE — Treatment with levodopa, alone or in combination Newsletter Article 15 February 2013 Pages: 19 - 20